Delaware Chapter 11: Sienna Biopharmaceuticals, Inc
Documents Can Be Accessed by Clicking on Any Heading Introduction On September 16, 2019 (the “Petition Date”), Sienna Biopharmaceuticals, Inc. (the “Debtor”) filed a voluntary petition for relief under chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The Debtor is represented by Latham & Watkins LLP […]